Regnum Corp.
Regnum Corp.
Your view on RGMP
Overview
What the company does, where it operates, and who runs it.
About Regnum Corp.
- Industry
- Entertainment
- Sector
- Communication Services
- CEO
- Robert J. Stubblefield
- Headquarters
- 600 Third Avenue, New York City, NY, US
- Industry
- Entertainment
- Sector
- Communication Services
- CEO
- Robert J. Stubblefield
- Headquarters
- 600 Third Avenue, New York City, NY, US
Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C—C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells.
The company is based in New York, New York. Regnum Corp. is a subsidiary of Phoenixus AG.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Regnum Corp., and the rating behind it. RGMP last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Regnum Corp.. Starting points for Regnum Corp.: EPS -$0.03, beta -0.47 — an Entertainment name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Regnum Corp.. Regnum Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Regnum Corp.. Trailing twelve-month EPS for Regnum Corp. stands at -$0.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Regnum Corp.. Regnum Corp. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Regnum Corp. valued side by side against its closest peers. Regnum Corp. is measured against Entertainment peers within the Communication Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Regnum Corp., and how their positions are changing. At a $2,295 market value, institutional positions materially move Regnum Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Regnum Corp. executives and directors. Shares of Regnum Corp. have traded between $0.0001 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Regnum Corp.. Regnum Corp. is a $2,295 Communication Services company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Regnum Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Regnum Corp.. Coverage tracks Regnum Corp. within Entertainment (Communication Services). Press releases and market coverage, newest first.